Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis

FASEB Journal

Volumn 22, Issue 2, 2008, Pages 355-364

  Zou, Lin ^a,c   Yang, Rongxi ^a,b   Chai, Jingjing ^a   Pei, Gang ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Matrix metalloproteinase 9; MMP9; Phosphatidylinositol 3 kinase; PI3K; Vascular endothelial growth factor; VEGF

Indexed keywords

BETA ARRESTIN; GELATINASE B; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CAPILLARY; CONTROLLED STUDY; ENZYME ACTIVITY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR GROWTH; XENOGRAFT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ARRESTINS; CELL LINE; DISEASE PROGRESSION; ENZYME ACTIVATION; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS; MUS MUSCULUS;

EID: 38949163338     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-9046com     Document Type: Article

References (45)

1. Lefkowitz, R. J., and Whalen, E. J. (2004) β-arrestins: traffic cops of cell signaling. Curr. Opin. Cell Biol. 16, 162-168
2. Lefkowitz, R. J., and Shenoy, S. K. (2005) Transduction of receptor signals by beta-arrestins. Science 308, 512-517
3. Shenoy, S. K., and Lefkowitz, R. J. (2005) Seven-transmembrane receptor signaling through beta-arrestin. Sci STKE, 2005, cm10
4. DeWire, S. M., Ahn, S., Lefkowitz, R. J., and Shenoy, S. K. (2007) Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510
5. Bryja, V., Gradl, D., Schambony, A., Arenas, E., and Schulte, G. (2007) Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 104, 6690-6695
6. Wang, P., Gao, H., Ni, Y., Wang, B., Wu, Y., Ji, L. Qin, L., Ma, L., and Pei, G. (2003) Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J. Biol. Chem. 278, 6363-6370
7. Chen, W., Kirkbride, K. C., How, T., Nelson, C. D., Mo, J., Frederick, J. P., Wang, X. F., Lefkowitz, R. J., and Blobe, G. C. (2003) Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science 301, 1394-1397
8. Girnita, L., Shenoy, S. K., Sehat, B., Vasilcanu, R., Vasilcanu, D., Girnita, A., Lefkowitz, R. J., and Larsson, O. (2007) Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J. Biol. Chem. 282, 11329-11338
9. Buchanan, F. G., Gorden, D. L., Matta, P., Shi, Q., Matrisian, L. M., and DuBois, R. N. (2006) Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. 103, 1492-1497
10. Wang, Y., Tang, Y., Teng, L., Wu, Y., Zhao, X., and Pei, G. (2006) Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7, 139-147
11. Dranoff, G. (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat. Rev. Cancer 4, 11-22
12. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70
13. Fidler, I. J. (1995) Modulation of the organ microenvironment for treatment of cancer metastasis. J. Natl. Cancer Inst. 87, 1588-1592
14. Boudreau, N., and Bissell, M. J. (1998) Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr. Opin. Cell Biol. 10, 640-646
15. Hayward, S. W., Grossfeld, G. D., Tlsty, T. D., and Cunha, G. R. (1998) Genetic and epigenetic influences in prostatic carcinogenesis. Int. J. Oncol. 13, 35-47
16. Paget, S. (1989) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 8, 98-101
17. Overall, C. M., and Kleifeld, O. (2006) Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6, 227-239
18. Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., and Opdenakker, G. (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375-536
19. Klein, G., Vellenga, E., Fraaije, M.W., Kamps, W. A., and de Bont, E. S. (2004) The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit. Rev. Oncol. Hematol. 50, 87-100
20. Fridman, R., Toth, M., Chvyrkova, I., Meroueh, S. O., and Mobashery, S. (2003) Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev. 22, 153-166
21. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744
22. Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., and Giavazzi, R. (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res. 63, 5224-5229
23. Ko, H. M., Kang, J. H., Choi, J. H., Park, S. J., Bai, S., Im, and S. Y. (2005) Platelet-activating factor induces matrix metalloproteinase-9 expression through Ca(2+)- or PI3K-dependent signaling pathway in a human vascular endothelial cell line. FEBS Lett. 579, 6451-6458
24. Choi, J. H., Choi, K. C., Auersperg. N., and Leung, P. C. (2006) Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells. Cancer Res. 66, 3912-3920
25. Wang, B., Xiao, Y., Ding, B. B., Zhang, N., Yuan, X., Gui, L., Qian, K. X., Duan. S., Chen, Z., Rao, Y., and Geng, J. G. (2003) Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 4, 19-29
26. Ma, Y. H., Hu, J. H., Zhou, X. G., Zeng, R. W., Mei, Z. T., Fei, J., Guo, L. H. (2000) Transgenic mice overexpressing gamma-aminobutyric acid transporter subtype I develop obesity. Cell Res. 10, 303-310
27. Kroger, A., Ortmann, D., Krohne, T. U., Mohr, L., Blum, H. E., Hauser, H., and Geissler, M. (2001) Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice. Cancer Res. 61, 2609-2617
28. Grimm, C. F., Ortmann, D., Mohr, L., Michalak, S., Krohne, T. U., Meckel, S., Eisele, S., Encke, J., Blum, H. E., and Geissler, M. (2000) Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology 119, 1104-1112
29. Byrne, A. M., Bouchier-Hayes, D. J., and Harmey, J. H. (2005) Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J. Cell. Mol. Med. 9, 777-794
30. Carmeliet, P. (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69, 4-10
31. Gavard, J., and Gutkind, J. S. (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8, 1223-1234
32. Wang, P., and DeFea, K. A. (2006) Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase. Biochemistry 45, 9374-9385
33. Abecassis, I., Olofsson, B., Schmid, M., Zalcman, G., and Karniguian, A. (2003) RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Exp. Cell Res. 291, 363-376
34. Mueller, M. M., and Fusenig, N. E. (2004) Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839-849
35. Revankar, C. M., Vines, C. M., Cimino, D. F., and Prossnitz, E. R. (2004) Arrestins block G protein-coupled receptor-mediated apoptosis. J. Biol. Chem. 279, 24578-24584
36. Sun, Y., Cheng, Z., Ma, L., and Pei, G. (2002) Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277, 49212-49219
37. Egeblad, M., and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174
38. Huang, S., Arsdall, M. V., Tedjarati, S., McCarty, M., Wu, W., Langley, R., and Fidler, I. J. (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth in human ovarian carcinoma in mice. J. Natl. Cancer Inst. 94, 1134-1142
39. Jain, R. K. (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62
40. Povsic, T. J., Kohout, T. A., and Lefkowitz, R. J. (2003) Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J. Biol. Chem. 278, 51334-51339
41. DeFea, K. A., Vaughn, Z. D., O'Bryan, E. M., Nishijima, D., Dery, O., and Bunnett, N. W. (2000) The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. Proc. Natl. Acad. Sci. U. S. A. 97, 11086-11091
42. Dery, O., Thoma, M. S., Wong, H., Grady, E. F., and Bunnett, N. W. (1999) Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor. J. Biol. Chem. 274, 18524-18535
43. Morris, D. R., Ding, Y., Ricks, T. K., Gullapalli, A., Wolfe, B. L., and Trejo, J. (2006) Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res. 66, 307-314
44. Wang, P., Wu, Y., Ge, X., Ma, L., and Pei, G. (2003) Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J. Biol. Chem. 278, 11648-11653
45. Kang, J., Shi, Y., Xiang, B., Qu, B., Su, W., Zhu, M., Zhang, M., Bao, G., Wang, F., Zhang, X., Yang, R., Fan, F., Chen, X., Pei, G., and Ma, L. (2005) A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123, 833-847